[HTML][HTML] The neurokinin-1 receptor antagonist aprepitant: an intelligent bullet against cancer?
M Muñoz, R Coveñas - Cancers, 2020 - mdpi.com
Simple Summary Due to the lack of selectivity and the severe side-effects, cytostatics are the
drugs of the present but not of the future and consequently new anticancer strategies must …
drugs of the present but not of the future and consequently new anticancer strategies must …
The role of heat shock proteins in metastatic colorectal cancer: A review
Heat shock proteins (HSPs) are a large molecular chaperone family classified by their
molecular weights, including HSP27, HSP40, HSP60, HSP70, HSP90, and HSP110. HSPs …
molecular weights, including HSP27, HSP40, HSP60, HSP70, HSP90, and HSP110. HSPs …
[HTML][HTML] SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant
Aims Prostate cancer continues to be one of the main global health issues in men.
Neuropeptide substance P (SP) acting via neurokinin-1receptor (NK1R) promotes …
Neuropeptide substance P (SP) acting via neurokinin-1receptor (NK1R) promotes …
[HTML][HTML] Can aloin develop to medicines or healthcare products?
Y Yang, J Wu, J Xia, Y Wan, JF Xu, L Zhang… - Biomedicine & …, 2022 - Elsevier
In folk medicine, Aloe, a genus of Aloaceae, is constantly developed into laxative drugs or
products and skin remedies with tremendous popularity worldwide. However, almost all …
products and skin remedies with tremendous popularity worldwide. However, almost all …
Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer …
M Tajaldini, M Saeedi, T Amiriani, AH Amiriani… - European Journal of …, 2022 - Elsevier
The tumor microenvironment (TME) and its components have recently attracted tremendous
attention in cancer treatment strategies, as alongside the genetic and epigenetic alterations …
attention in cancer treatment strategies, as alongside the genetic and epigenetic alterations …
Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer
M Mozafari, S Ebrahimi, RA Darban… - Molecular Biology …, 2022 - Springer
Background Cervical cancer, an aggressive gynecological cancer, seriously threatens
women's health worldwide. It is recently reported that neuropeptide substance P (SP) …
women's health worldwide. It is recently reported that neuropeptide substance P (SP) …
The in vitro anti‐cancer synergy of neurokinin‐1 receptor antagonist, aprepitant, and 5‐aminolevulinic acid in glioblastoma
Glioblastoma multiforme (GBM) is the most malignant type of cerebral neoplasm in adults
with a poor prognosis. Currently, combination therapy with different anti‐cancer agents is at …
with a poor prognosis. Currently, combination therapy with different anti‐cancer agents is at …
The effect of SP/NK1R on the expression and activity of catalase and superoxide dismutase in glioblastoma cancer cells
F Korfi, H Javid, R Assaran Darban… - Biochemistry …, 2021 - Wiley Online Library
Introduction. Glioblastoma is the most malignant brain tumor with different therapeutic
protocols, including surgery, radiotherapy, and chemotherapy. Substance P (SP), a peptide …
protocols, including surgery, radiotherapy, and chemotherapy. Substance P (SP), a peptide …
The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells
M Momen Razmgah, A Ghahremanloo, H Javid… - Molecular biology …, 2022 - Springer
Abstract Background Substance P (SP) has a crucial role in cancer initiation and
progression via binding to its specific receptor (NK1R). Various evidence confirmed the …
progression via binding to its specific receptor (NK1R). Various evidence confirmed the …
The potential in vitro inhibitory effects of neurokinin‐1 receptor (NK‐1R) antagonist, aprepitant, in osteosarcoma cell migration and metastasis
MA Alsaeed, S Ebrahimi, A Alalikhan… - BioMed Research …, 2022 - Wiley Online Library
Background. Osteosarcoma, the most frequent osteogenic malignancy, has become a
serious public health challenge due to its high morbidity rates and metastatic potential …
serious public health challenge due to its high morbidity rates and metastatic potential …